Vero Biotech Inc. — Form D

Vero Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-22. The offering totals $99.5M, of which $27.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Eric V BednarskiDirectorAtlanta, GA
Todd BradyDirectorAtlanta, GA
Brent V FurseDirectorAtlanta, GA
Daniel SalazarDirectorClinton, MA
Thiago V TavaresDirectorAtlanta, GA
Roberto V CohenExecutive OfficerAtlanta, GA
Brent V FurseExecutive OfficerAtlanta, GA
Shasha V ZouExecutive OfficerAtlanta, GA
James O'BrienDirectorNew York, NY
James O'BrienExecutive OfficerNew York, NY
Paul Scott AntinoriExecutive OfficerConcord, MA
Steven ShulmanDirectorNew York, NY
Steven ShulmanExecutive OfficerNew York, NY
Todd Scott BradyDirectorCocoa, FL
Theo Scott Melas-KyriaziDirectorCocoa, FL
Brent H FurseDirectorCocoa, FL
Brent H FurseExecutive OfficerCocoa, FL
Vinzenz Scott PloererDirectorCocoa, FL
David H Fine, Ph.D.DirectorCocoa, FL
David H Fine, Ph.D.Executive OfficerCocoa, FL
Tod Scott ShultzExecutive OfficerCocoa, FL
Dan Scott Salazar, Ph.D.DirectorCocoa, FL
Anthony Scott LoumidisExecutive OfficerCocoa, FL
T. Scott Johnson, M.D.DirectorCocoa, FL
Theo Melas-KyriaziDirectorCambridge, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2017-09-29D$35.1M$29.9M
2013-10-18D/A$17.0M$14.7M
2013-10-03D$14.6M$14.6M
2011-12-29D$10.5M$8.0M
2009-09-14D$3.0M$2.1M
2009-09-14D$3.5M$2.1M

More